Teladoc Q2 2026 Results Hit by BetterHelp Shift

Teladoc Health, Inc. (NYSE: TDOC) trimmed its full-year revenue outlook after reporting second-quarter 2026 results that reflected a shift in BetterHelp demand from cash-pay to insurance-covered services. Management said provider-capacity limits slowed the conversion of that demand, squeezing near-term revenue.

Quarter Results and Guidance

Teladoc reported consolidated revenue of $606.9 million for the second quarter, below consensus near $615 million, in a press release on July 29, 2026, at 4:05 p.m. ET. The company lowered full-year consolidated revenue guidance to $2.36 billion–$2.45 billion, a 5% midpoint reduction from the prior range. Integrated Care revenue rose 1% year over year to $394.3 million, with management noting improved profitability in that segment.

The quarter’s revenue declined 4% from $631.9 million a year earlier. Teladoc recorded a net loss of $38.9 million, or $0.21 per diluted share, compared with a loss of $0.19 per share in the prior year. BetterHelp revenue totaled about $213 million, down 11.6% year over year and 2.6% sequentially.

BetterHelp Shift and Market Reaction

Management said cash-pay pressure accelerated in late May and June, while insurance-covered demand for BetterHelp outpaced available provider capacity. This limited session volume and near-term revenue conversion, which management identified as the primary reason for the revenue guidance cut. The company also projected third-quarter revenue of $569 million–$609 million.

Shares fell more than 20% before the bell on July 30, 2026, at 7:21 a.m. ET. Although the quarter fell within the company’s consolidated guidance, the weaker outlook overshadowed stronger Integrated Care profitability. Investors are assessing whether those gains will offset near-term revenue risks as Teladoc expands provider and network capacity to meet rising insured demand.